Please provide your email address to receive an email when new articles are posted on . WASHINGTON — A phase 2 study found that ST-100, a collagen mimetic peptide, could provide a new avenue for ...
STUART, Fla., June 24, 2025 /PRNewswire/ -- Stuart Therapeutics, Inc., a clinical-stage drug platform company developing novel therapies for ophthalmic diseases, today announced the initial results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results